RoyceAlanMorrisonMD

PubMed

• 12 citations
  Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist.
  Brendan M. Johnson, Laurel M. Adams, Ke Zhang, Shelby D. Gainer, Lyndon C. Kirby
  Journal of Clinical Pharmacology. 2010-08-01

Journal Articles

• Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy  
  Jamois C, Smith P, Morrison R et al, Addiction Biology, 1/1/2009
• The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans  
  von Eschen K, Morrison R et al, Human Vaccines, 1/1/2009
• Randomized study of phentolamine mesylate for reversal of local anesthesia  
  Laviola M et al, J Dental Research, 1/1/2008
• Characterization of the Human QT Interval : Novel Distribution-Based Assessment of the Repolarization Effects of Moxifloxacin  
  Holzgrefe H, Ferber G, Morrison R et al, Journal of Clinical Pharmacology
• Join now to see all

Abstracts/Posters

• Blinded Identification of Clinical QT Prolongation with Moxifloxacin Employing Distribution-based QT Analysis
  Holzgrefe H and Morrison R, Society of Toxicology Annual Meeting, 1/1/2011
• Single-center, Triple blind, Triple-dummy, Randomized, Single-dose, Four-way Crossover Phase I Study to Define the ECG Effects of Zabofloxacin Using a Clinical and Sup...
  Morrison R, Wikler MA, Rock JA, Morganroth J, International Conference on Antimicrobial Agents and Chemotherapy, 1/1/2010

Lectures

• Little Data, Big Decisions: Plan to Minimize Early-Phase Dilemmas 
  1/1/2015
• Implications of Clinical Test Result and ECG Variability for Design, Conduct and Interpretation of Early Phase Clinical Studies 
  1/1/2015
• Managing Under Pressure – Ocean of Change 
  1/1/2014
• Stakeholder Challenges in Early-Phase Studies of Potentially High-Risk Products 
  1/1/2014
• Gene Therapy 
  1/1/2014
• Certification: A US Early-Phase Perspective 
  1/1/2014
• Site Certification of Early-Phase Research Units: An International Perspective 
  1/1/2014
• Pharmacometrics: Implications and Impact in Preclinical and Early Phase Clinical Development 
  1/1/2013
• Opportunities to Take Advantage of Pharmacometrics 
  1/1/2013
• QT Derisking With Continuous ECG Data Analysis 
  1/1/2012
• Biosimilars and Clinical Trials – What are the Issues? 
  1/1/2010
• When Drugs Have Heart Attacks 
  1/1/2009
• Join now to see all